Nanoform Finland Oyj (HEL:NANOFH)
Finland · Delayed Price · Currency is EUR 0.6740
+0.0140 (2.12%)
Mar 19, 2026, 2:45 PM EET
Nanoform Finland Oyj Revenue
In the year 2025, Nanoform Finland Oyj had annual revenue of 5.02M EUR with 37.10% growth. Nanoform Finland Oyj had revenue of 2.82M in the quarter ending December 31, 2025, with 72.19% growth.
Revenue
5.02M
Revenue Growth
+37.10%
P/S Ratio
11.26
Revenue / Employee
29.37K
Employees
171
Market Cap
56.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.02M | 1.36M | 37.10% |
| Dec 31, 2024 | 3.66M | 1.10M | 42.72% |
| Dec 31, 2023 | 2.57M | -920.89K | -26.41% |
| Dec 31, 2022 | 3.49M | 1.53M | 78.42% |
| Dec 31, 2021 | 1.95M | 1.25M | 178.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orion Oyj | 1.89B |
| Terveystalo Oyj | 1.28B |
| Pihlajalinna Oyj | 652.53M |
| Revenio Group Oyj | 109.90M |
| Optomed Oyj | 17.10M |
| Biohit Oyj | 15.70M |
| Nexstim | 12.41M |
| Modulight Oyj | 10.51M |
Nanoform Finland Oyj News
- 17 days ago - Nanoform Finland Oyj: The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees - Finanz Nachrichten
- 19 days ago - Nanoform Finland PLC (FRA:4YL) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... - GuruFocus
- 19 days ago - Q4 2025 Nanoform Finland Oyj Earnings Call Transcript - GuruFocus
- 21 days ago - Nanoform Finland Oyj: Nanoform Q4 & FY2025 report - Next: the submission of a marketing authorization application for Nanoenzalutamide in Europe - Finanz Nachrichten
- 2 months ago - Nanoform Finland Oyj: Inside information: Nanoform starts change negotiations as part of announced new midterm business targets for 2030 - Finanz Nachrichten
- 3 months ago - Nanoform Finland Oyj: Inside information: Nanoform announces new midterm business targets for 2030 - Finanz Nachrichten
- 4 months ago - Nanoform Finland PLC (FRA:4YL) Q3 2025 Earnings Call Highlights: Strong Cash Flow and Strategic ... - GuruFocus
- 4 months ago - Q3 2025 Nanoform Finland Oyj Earnings Call Transcript - GuruFocus